The elevated serum level of chemerin was positively associated with advanced clinical stages and poorer overall and disease-free survivals in patients with gastric cancer or NSCLC [6,9] but with improved overall survival in patients with adrenocortical carcinoma [7]. This evidence concerns the gene RARRES2 and gastric cancer.